Effect of docetaxel on C-jun and androgen receptor interaction in prostate cancer LNCaP cells and its androgen-independence subtype LNCaP-bic cells / 南方医科大学学报
Journal of Southern Medical University
;
(12): 1461-1464, 2012.
Artículo
en Chino
| WPRIM
| ID: wpr-315441
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the effect of docetaxel on the interaction between C-jun and androgen receptor (AR) in prostate cancer LNCaP cells and its androgen-independence subtype LNCaP-bic cells.</p><p><b>METHODS</b>LNCaP and LNCaP-bic cells were treated with docetaxel and the changes in AR and AP-1 expression were evaluated using luciferase assay. Western blotting and immunoprecipitation assay were employed to analyze the effects of docetaxel on the expressions of C-jun and AR and their interaction.</p><p><b>RESULTS</b>Luciferase assay showed that LNCaP and LNCaP-bic cells expressed higher levels of AR and C-jun after docetaxel treatment. Docetaxel induced a higher level of p-c-jun expression in LNCaP-bic cells than in the parental LNCaP cells. Western blotting showed a strong PSA protein expression in LNCaP-bic cell after docetaxel treatment. Docetaxel caused a stronger interaction between AR and C-jun in LNCaP-bic cells.</p><p><b>CONCLUSION</b>Docetaxel activates ligand-independent AR transcription, and the interaction between AR and C-jun may affect the outcome of docetaxel chemotherapy.</p>
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Farmacología
/
Próstata
/
Neoplasias de la Próstata
/
Receptores Androgénicos
/
Proteínas Proto-Oncogénicas c-jun
/
Línea Celular Tumoral
/
Taxoides
/
Metabolismo
Límite:
Humanos
/
Masculino
Idioma:
Chino
Revista:
Journal of Southern Medical University
Año:
2012
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS